Matilde Y. Follo

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text

Medicine, Genetics, Hematology +16

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 636 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Matilde Y. Follo, Carlo Finelli, Sara Mongiorgi et al. · Proceedings of the National Academy of Sciences · 2009 · 121 citations · Full text

Medicine, Oncology, Pharmacology +16

Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients

Maria Nyåkern, Pier Luigi Tazzari, Carlo Finelli et al. · Leukemia · 2005 · 101 citations

Medicine, Hematology, Molecular Medicine +12

The Akt/Mammalian Target of Rapamycin Signal Transduction Pathway Is Activated in High-Risk Myelodysplastic Syndromes and Influences Cell Survival and Proliferation

Matilde Y. Follo, Sara Mongiorgi, Costanza Bosi et al. · Cancer Research · 2007 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17